封面
市場調查報告書
商品編碼
1513218

聚合酵素鏈鎖反應(PCR) 技術 2024 年全球市場報告

Polymerase Chain Reaction (PCR) Technologies Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

PCR技術的市場規模預計在未來幾年將快速成長。 2028年,將以12.1%的複合年成長率成長至230.2億美元。這種成長的推動因素包括對快速準確疾病診斷的需求增加、對法醫學的興趣增加、即時聚合酵素鏈鎖反應技術的廣泛採用、對快速現場診斷測試的需求激增以及感染疾病爆發的增加和伴同性診斷預計將受到日益成長的需求的推動。預測期內預計的主要趨勢包括次世代定序(NGS)、RNA 檢測和分析、單細胞 PCR 分析、生物資訊軟體和資料分析工具的進步、微流體技術和實驗室晶片系統、就地檢驗(POCT),以及人工智慧(AI)和資料分析的整合。

感染疾病病率的增加預計將推動 PCR 技術市場的未來成長。感染疾病是指由細菌、病毒、寄生蟲、真菌等病原微生物引起的、可在人與人之間直接或間接傳播的疾病。感染疾病的日益流行凸顯了病原體帶來的日益嚴峻的挑戰,這可能受到全球化、都市化、抗菌素抗藥性和環境變化等因素的影響。 PCR技術透過檢測和擴增病原體的特異性遺傳物質,以高靈敏度和精確度促進病原體的識別和診斷,在感染疾病控制中發揮重要作用。例如,2023年11月,總部位於瑞士、負責全球公共衛生的聯合國專門機構世界衛生組織(WHO)宣布,2022年全球將出現1,060萬例結核病病例,預計將達到580例。萬女性和130 萬兒童。因此,感染疾病的日益普及正在推動PCR技術市場的發展。

PCR 技術市場的主要企業致力於先進的技術解決方案,以提高分子診斷的準確性、靈敏度和效率,例如下一代定量聚合酵素鏈鎖反應(qPCR) 技術。定量聚合酵素鏈鎖反應(qPCR) 技術可量化樣本中的特定 DNA 序列並提供即時監測和擴增,已成為科學和醫學領域的必備技術。例如,瑞士生物技術公司 F. Hoffmann La Roche 於 2023 年 11 月剛發布了 LightCycler PRO 系統。這種新一代 qPCR 系統旨在滿足分子診斷的臨床需求並應對公共衛生挑戰。我們的目標是成為臨床診斷和研究領域的尖端 qPCR 技術,縮小轉化研究和體外診斷之間的差距,同時提高性能和易用性。該系統利用黃金標準技術,確保了準確的患者診斷和明智的臨床決策所需的品質、準確性和可靠性。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場表現:規模與成長,2018-2023 年
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場預測:規模與成長,2023-2028 年,2033F

第6章 市場細分

  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:依產品分類的表現與預測,2018-2023、2023-2028F、2033F
  • 試劑及耗材
  • 裝置
  • 軟體
  • 服務
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:依技術分類的表現與預測,2018-2023、2023-2028F、2033F
  • 即時聚合酵素鏈鎖反應
  • 常規聚合酵素鏈鎖反應
  • 逆轉錄聚合酵素鏈鎖反應
  • 數位聚合酵素鏈鎖反應
  • 多重即時 (RT)聚合酵素鏈鎖反應
  • 熱啟動聚合酵素鏈鎖反應
  • 其他技術
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:按應用分類的表現與預測,2018-2023、2023-2028F、2033F
  • 基因表現分析
  • 基因序列分析
  • 基因型鑒定
  • 核酸合成
  • 標準檢驗
  • 照護現場診斷
  • 環境應用
  • 其他用途
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:最終用戶的實際狀況與預測,2018-2023、2023-2028F、2033F
  • 醫院和診斷中心
  • 研究實驗室和學術機構
  • 製藥和生物技術公司
  • 其他最終用戶

第 7 章 區域/國家分析

  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:按地區分類的表現與預測,2018-2023、2023-2028F、2033F
  • 全球聚合酵素鏈鎖反應(PCR) 技術市場:按國家分類的表現和預測,2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 聚合酵素鏈鎖反應(PCR) 技術市場:競爭型態
  • 聚合酵素鏈鎖反應(PCR) 技術市場:公司簡介
    • F. Hoffmann-La Roche Ltd.
    • Bayer Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 其他重大及創新企業

  • Siemens Healthineers AG
  • Becton, Dickinson and Company(BD)
  • GE Healthcare Technologies LLC
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Eurofins Scientific SE
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Beckman Coulter Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • QIAGEN NV
  • Natera Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18205

Polymerase chain reaction (PCR) technologies are laboratory techniques utilized to amplify and analyze DNA sequences, serving as a cornerstone tool in molecular biology. They find widespread application in genetic testing, diagnostics, forensics, and research.

The primary products associated with PCR technologies include reagents and consumables, instruments, software, and services. Reagents and consumables encompass materials, chemicals, or supplies consumed during scientific experiments, research, or industrial processes. Various PCR technologies are employed, such as real-time PCR, conventional PCR, reverse transcription PCR, digital PCR, multiplex real-time PCR, hot start PCR, among others. These technologies cater to diverse applications including gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point-of-care diagnostics, and environmental applications. End-users of PCR technologies include hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, among others.

The PCR technologies research report is one of a series of new reports from The Business Research Company that provides PCR technologies market statistics, including the PCR technologies industry's global market size, regional shares, competitors with a PCR technologies market share, detailed PCR technologies market segments, market trends and opportunities, and any further data you may need to thrive in the PCR technologies industry. This PCR technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The PCR technologies market size has grown rapidly in recent years. It will grow from $13.03 billion in 2023 to $14.58 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth can be attributed to an increased number of genome-based drug development activities, a rise in the prevalence of genetic disorders and target diseases, heightened utilization of miniaturized portable instruments, increased adoption of biomarker profiling, and a growing demand for personalized medicine.

The PCR technologies market size is expected to see rapid growth in the next few years. It will grow to $23.02 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth is expected to be driven by an increased demand for rapid and accurate disease diagnosis, growing interest in forensics, wider adoption of real-time polymerase chain reaction technology, a surge in demand for rapid on-site diagnostic testing, a rise in infectious disease outbreaks, and a growing need for companion diagnostics. Key trends anticipated in the forecast period include integration of next-generation sequencing (NGS), RNA detection and analysis, single-cell PCR analysis, advancements in bioinformatics software and data analysis tools, microfluidic technologies, lab-on-a-chip systems, and point-of-care testing (POCT), as well as the integration of artificial intelligence (AI) and data analytics.

An increasing prevalence of infectious diseases is expected to propel the growth of the PCR technologies market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can spread directly or indirectly from one person to another. The rising incidence of infectious diseases underscores the mounting challenges posed by pathogens, likely influenced by factors such as globalization, urbanization, antimicrobial resistance, and environmental changes. PCR technologies play a crucial role in combating infectious diseases by detecting and amplifying specific genetic material of pathogens, facilitating their identification and diagnosis with high sensitivity and accuracy. For instance, in November 2023, according to the World Health Organization (WHO), a Switzerland-based specialized agency of the United Nations responsible for international public health, 10.6 million cases of tuberculosis (TB) are predicted to occur globally in 2022, affecting 5.8 million men, 3.5 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is driving the PCR technologies market.

Major companies in the PCR technologies market are dedicated to advancing technological solutions, such as next-gen quantitative polymerase chain reaction (qPCR) technologies, to enhance accuracy, sensitivity, and efficiency in molecular diagnostics. Quantitative polymerase chain reaction (qPCR) technology quantifies specific DNA sequences in samples, offering real-time monitoring and amplification, making it indispensable across scientific and medical disciplines. For instance, F. Hoffmann-La Roche AG, a Switzerland-based biotechnology company, recently introduced the LightCycler PRO System in November 2023. This next-generation qPCR system is designed to meet clinical needs in molecular diagnostics and address public health challenges. It aims to be the most advanced qPCR technology for both clinical diagnostics and research, offering improved performance and usability while bridging the gap between translational research and in vitro diagnostics. Leveraging gold-standard technology, this system ensures quality, precision, and reliability crucial for precise patient diagnosis and informed clinical decisions.

In May 2023, Transformative Biotech LLC, a US-based startup biotechnology company, acquired Summit Biolabs with the aim of implementing rapid and highly accurate direct-to-polymerase chain reaction (PCR) technologies. Summit Biolabs, another US-based biotechnology company, specializes in developing innovative molecular diagnostic solutions and direct-to-PCR technologies, poised to revolutionize the biotechnology industry.

Major companies operating in the polymerase chain reaction (PCR) technologies market are F. Hoffmann-La Roche Ltd., Bayer Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company (BD), GE Healthcare Technologies LLC, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ambry Genetics Corporation, Veritas Genetics Inc.

North America was the largest region in the PCR technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polymerase chain reaction (PCR) technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The PCR technologies market consists of revenues earned by entities by providing services such as gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The PCR technologies market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction (PCR) Technologies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction (PCR) technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction (PCR) technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The polymerase chain reaction (PCR) technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Reagents And Consumables; Instruments; Software; Services
  • 2) By Technology: Real-Time Polymerase Chain Reaction; Conventional Polymerase Chain Reaction; Reverse Transcription Polymerase Chain Reaction; Digital Polymerase Chain Reaction; Multiplex Real-Time (RT) Polymerase Chain Reaction; Hot Start Polymerase Chain Reaction; Other Technologies
  • 3) By Application: Gene Expression Analysis; Genetic Sequencing; Genotyping; Nucleic Acid Synthesis; Standard Validation; Point Of Care Diagnostics; Environmental Application; Other Applications
  • 4) By End Users: Hospitals And Diagnostic Centers; Research Laboratories And Academic Institutes; Pharmaceutical And Biotechnology Companies; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Bayer Corporation; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction (PCR) Technologies Market Characteristics

3. Polymerase Chain Reaction (PCR) Technologies Market Trends And Strategies

4. Polymerase Chain Reaction (PCR) Technologies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Polymerase Chain Reaction (PCR) Technologies Market Size and Growth

  • 5.1. Global Polymerase Chain Reaction (PCR) Technologies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Polymerase Chain Reaction (PCR) Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Polymerase Chain Reaction (PCR) Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Polymerase Chain Reaction (PCR) Technologies Market Segmentation

  • 6.1. Global Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents And Consumables
  • Instruments
  • Software
  • Services
  • 6.2. Global Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Real-Time Polymerase Chain Reaction
  • Conventional Polymerase Chain Reaction
  • Reverse Transcription Polymerase Chain Reaction
  • Digital Polymerase Chain Reaction
  • Multiplex Real-Time (RT) Polymerase Chain Reaction
  • Hot Start Polymerase Chain Reaction
  • Other Technologies
  • 6.3. Global Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gene Expression Analysis
  • Genetic Sequencing
  • Genotyping
  • Nucleic Acid Synthesis
  • Standard Validation
  • Point Of Care Diagnostics
  • Environmental Application
  • Other Applications
  • 6.4. Global Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Diagnostic Centers
  • Research Laboratories And Academic Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End Users

7. Polymerase Chain Reaction (PCR) Technologies Market Regional And Country Analysis

  • 7.1. Global Polymerase Chain Reaction (PCR) Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Polymerase Chain Reaction (PCR) Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market

  • 8.1. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Polymerase Chain Reaction (PCR) Technologies Market

  • 9.1. China Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 9.2. China Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Polymerase Chain Reaction (PCR) Technologies Market

  • 10.1. India Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Polymerase Chain Reaction (PCR) Technologies Market

  • 11.1. Japan Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 11.2. Japan Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Polymerase Chain Reaction (PCR) Technologies Market

  • 12.1. Australia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Polymerase Chain Reaction (PCR) Technologies Market

  • 13.1. Indonesia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Polymerase Chain Reaction (PCR) Technologies Market

  • 14.1. South Korea Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 14.2. South Korea Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Polymerase Chain Reaction (PCR) Technologies Market

  • 15.1. Western Europe Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 15.2. Western Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Polymerase Chain Reaction (PCR) Technologies Market

  • 16.1. UK Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Polymerase Chain Reaction (PCR) Technologies Market

  • 17.1. Germany Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Polymerase Chain Reaction (PCR) Technologies Market

  • 18.1. France Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Polymerase Chain Reaction (PCR) Technologies Market

  • 19.1. Italy Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Polymerase Chain Reaction (PCR) Technologies Market

  • 20.1. Spain Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market

  • 21.1. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 21.2. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Polymerase Chain Reaction (PCR) Technologies Market

  • 22.1. Russia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Polymerase Chain Reaction (PCR) Technologies Market

  • 23.1. North America Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 23.2. North America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Polymerase Chain Reaction (PCR) Technologies Market

  • 24.1. USA Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 24.2. USA Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Polymerase Chain Reaction (PCR) Technologies Market

  • 25.1. Canada Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 25.2. Canada Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Polymerase Chain Reaction (PCR) Technologies Market

  • 26.1. South America Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 26.2. South America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Polymerase Chain Reaction (PCR) Technologies Market

  • 27.1. Brazil Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Polymerase Chain Reaction (PCR) Technologies Market

  • 28.1. Middle East Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 28.2. Middle East Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Polymerase Chain Reaction (PCR) Technologies Market

  • 29.1. Africa Polymerase Chain Reaction (PCR) Technologies Market Overview
  • 29.2. Africa Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Polymerase Chain Reaction (PCR) Technologies Market, Segmentation By End Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Polymerase Chain Reaction (PCR) Technologies Market Competitive Landscape And Company Profiles

  • 30.1. Polymerase Chain Reaction (PCR) Technologies Market Competitive Landscape
  • 30.2. Polymerase Chain Reaction (PCR) Technologies Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Polymerase Chain Reaction (PCR) Technologies Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers AG
  • 31.2. Becton, Dickinson and Company (BD)
  • 31.3. GE Healthcare Technologies LLC
  • 31.4. Laboratory Corporation of America Holdings
  • 31.5. Quest Diagnostics Incorporated
  • 31.6. Eurofins Scientific SE
  • 31.7. Agilent Technologies Inc.
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Inc.
  • 31.10. bioMerieux SA
  • 31.11. Beckman Coulter Inc.
  • 31.12. Sysmex Corporation
  • 31.13. Bio-Rad Laboratories Inc.
  • 31.14. QIAGEN N.V.
  • 31.15. Natera Inc.

32. Global Polymerase Chain Reaction (PCR) Technologies Market Competitive Benchmarking

33. Global Polymerase Chain Reaction (PCR) Technologies Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Technologies Market

35. Polymerase Chain Reaction (PCR) Technologies Market Future Outlook and Potential Analysis

  • 35.1 Polymerase Chain Reaction (PCR) Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Polymerase Chain Reaction (PCR) Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Polymerase Chain Reaction (PCR) Technologies Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer